文献速递脑血管病

原发性胶质瘤患者颅脑放疗后卒中的频率、危险因素与结局

Frequency, Risk Factors, and Outcomes of Strokes in Patients With Primary Glioma After Cranial Radiation Therapy.
PubMed 文献 · Neurology · 2025-07-17

这项单中心回顾性队列研究纳入2005至2021年间接受颅脑放疗的930例胶质瘤患者,最终分析910例。10.0%的患者发生卒中,其中73.6%为缺血性,15.4%复发;多变量分析显示黑种人、放射性坏死和高脂血症与全因卒中风险升高相关,出血性卒中后残疾更重。

要点

  • 胶质瘤放疗后约十分之一患者发生卒中,以缺血性为主。
  • 放射性坏死和高脂血症是全因及缺血性卒中的独立危险因素。
  • 出血性卒中较缺血性卒中导致更高的卒中后残疾。

核心结论

  • 在成人胶质瘤颅脑放疗后队列中,10.0%的患者后续诊断为卒中,15.4%发生复发性卒中。
  • 黑种人、放射性坏死和高脂血症与全因卒中风险升高显著相关。
  • 出血性卒中较缺血性卒中与更高的卒中后残疾相关。

研究设计与样本

  • 单中心回顾性队列研究,纳入2005至2021年间诊断并接受颅脑放疗的胶质瘤患者。
  • 930例患者中910例接受放疗并纳入最终分析,平均年龄53.8岁,40%为女性。

主要发现

  • 91例(10.0%)诊断为卒中,其中73.6%为缺血性,15.4%为复发性卒中。
  • 放疗开始至卒中诊断的中位时间为652天,复发性卒中的中位时间为102天。
  • 多变量分析显示黑种人(OR 3.41,95% CI 1.59-7.33)、放射性坏死(OR 6.42,95% CI 2.45-16.79)和高脂血症(OR 6.42,95% CI 3.91-10.57)与全因卒中风险升高显著相关。
  • 放射性坏死和高脂血症与缺血性卒中风险升高相关。
  • 黑种人、高脂血症和较年轻年龄与出血性卒中风险升高相关。

临床怎么用

  • 对胶质瘤放疗后患者,尤其合并放射性坏死或高脂血症者,应关注卒中风险并加强监测。

局限性

  • 回顾性设计。
  • 卒中检查不完整。
  • 缺乏分子诊断资料。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Radiation therapy is the mainstay of therapy for patients with glioma. While this treatment modality can improve survival, treatment-related complications may include radiation-induced vasculopathy and increased risk of stroke. We aimed to evaluate the stroke frequency, associated risk factors, and outcomes after cranial radiation therapy in patients with glioma. METHODS: This is a retrospective cohort study at a single tertiary academic brain tumor center involving patients diagnosed with gliomas between 2005 and 2021 who received cranial radiation therapy. Data were collected from the time of cranial radiation therapy until last follow-up. Logistic regression analyses were used to evaluate the association of clinical and demographic variables with all-cause, ischemic, and hemorrhagic strokes. RESULTS: In a retrospective cohort of 930 patients, 910 received radiation therapy (mean age 53.8 years; 40% women) and were included in the final analysis. A total of 91 patients (10.0%) were diagnosed with stroke (73.6% ischemic; 15.4% with recurrent strokes). The median time to diagnosis of stroke after onset of radiation therapy was 652 days with median time to recurrent stroke of 102 days. In a univariable model, Black race (odds ratio [OR] 3.83, 95% CI 1.94-7.56), radiation necrosis (OR 4.62, 95% CI 2.02-10.55), hypertension (OR 1.93, 95% CI 1.23-3.01), hyperlipidemia (OR 5.93, 95% CI 3.61-9.57), and diabetes mellitus (OR 2.25, 95% CI 1.28-3.95) were associated with higher odds of all-cause stroke. In multivariable analysis, Black race (OR 3.41, 95% CI 1.59-7.33), radiation necrosis (OR 6.42, 95% CI 2.45-16.79), and hyperlipidemia (OR 6.42, 95% CI 3.91-10.57) were significantly associated with increased odds of all-cause stroke. Radiation necrosis and hyperlipidemia were associated with increased odds of ischemic stroke. Black race, hyperlipidemia, and younger age were associated with increased odds of hemorrhagic stroke. Compared with ischemic strokes, hemorrhagic strokes were associated with higher poststroke disability. DISCUSSION: In a large, retrospective cohort of adult patients with glioma treated with cranial radiation therapy, 1 in 10 patients were subsequently diagnosed with stroke with 15.4% suffering recurrent strokes. Factors associated with increased odds of stroke included Black race, radiation necrosis, and hyperlipidemia and should be validated in future prospective cohorts. Study limitations include the retrospective design, incomplete stroke workups, and lack of molecular diagnostics.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Ryan D, Sugita M, Broadwater G, et al. Frequency, Risk Factors, and Outcomes of Strokes in Patients With Primary Glioma After Cranial Radiation Therapy. Neurology. 2025. PMID: 40674668. doi:10.1212/WNL.0000000000213902

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。